Patents by Inventor Kenneth Welsh

Kenneth Welsh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160103135
    Abstract: The invention provides a method of detecting the presence of anti-MHC antibodies in a sample comprising contacting said sample with one or more recombinant MHC molecules or functionally equivalent variants, derivatives or fragments thereof and detecting the binding or absence of binding of antibodies to said recombinant MHC molecules. This method allows the detection and/or identification of one or more specific MHC particularly HLA allele antibodies.
    Type: Application
    Filed: August 6, 2015
    Publication date: April 14, 2016
    Applicants: OXFORD RADCLIFFE HOSPITAL NHS ("ORH") TRUST OF THE JOHN RADCLIFFE HOSPITAL, KING'S COLLEGE LONDON, GUY'S & ST. THOMAS' HOSPITAL NHS TRUST ("GST")
    Inventors: Martin BARNARDO, Andrea Harmer, Michael Bunce, Robert Vaughan, Kenneth Welsh
  • Publication number: 20150260622
    Abstract: The invention provides a method of depleting anti-MHC antibodies in a sample comprising contacting said sample with one or more recombinant MHC molecules or functionally equivalent variants, derivatives or fragments thereof and removing at least the recombinant MHC molecules to which antibodies to said recombinant MHC molecules contained within the sample have bound. This method allows the depletion of one or more specific MHC particularly HLA allele antibodies from a sample.
    Type: Application
    Filed: March 16, 2015
    Publication date: September 17, 2015
    Applicants: OXFORD RADCLIFFE HOSPITAL NHS ("ORH") TRUST OF THE JOHN RADCLIFFE HOSPITAL, KING'S COLLEGE LONDON, GUY'S & ST. THOMAS' HOSPITAL NHS TRUST ("GST")
    Inventors: Martin BARNARDO, Andrea Harmer, Michael Bunce, Robert Vaughan, Kenneth Welsh
  • Publication number: 20140273267
    Abstract: The invention provides a method of depleting anti-MHC antibodies in a sample comprising contacting said sample with one or more recombinant MHC molecules or functionally equivalent variants, derivatives or fragments thereof and removing at least the recombinant MHC molecules to which antibodies to said recombinant MHC molecules contained within the sample have bound. This method allows the depletion of one or more specific MHC particularly HLA allele antibodies from a sample.
    Type: Application
    Filed: October 4, 2013
    Publication date: September 18, 2014
    Applicants: GUY'S &ST THOMAS' HOSPITAL NHS TRUST ('GST'), OXORD RADCLIFFE HOSPITAL NHS ('ORH") TRUST OF THE JOHN RADCLIFFE HOSPITAL, KING'S COLLEGE LONDON
    Inventors: Martin Barnardo, Andrea Harmer, Michael Bunce, Robert Vaughan, Kenneth Welsh
  • Publication number: 20140178857
    Abstract: The invention provides a method of detecting the presence of anti-MHC antibodies in a sample comprising contacting said sample with one or more recombinant MHC molecules or functionally equivalent variants, derivatives or fragments thereof and detecting the binding or absence of binding of antibodies to said recombinant MHC molecules. This method allows the detection and/or identification of one or more specific MHC particularly HLA allele antibodies.
    Type: Application
    Filed: November 13, 2013
    Publication date: June 26, 2014
    Applicants: GUY'S & ST THOMAS' HOSPITAL NHS TRUST ("GST"), OXFORD RADCLIFFE HOSPITAL NHS ("ORH") TRUST OF THE JOHN RADCLIFFE HOSPITAL, KING'S COLLEGE LONDON
    Inventors: Martin C. Barnardo, Andrea Harmer, Michael Bunce, Robert Vaughan, Kenneth Welsh
  • Patent number: 7745112
    Abstract: There are disclosed genetic screens for predicting the likely extent of tobacco consumption in human subjects based on screening for the presence or absence of genetic variants shown to be associated with tobacco consumption in smokers.
    Type: Grant
    Filed: November 24, 2000
    Date of Patent: June 29, 2010
    Assignee: g-Nostics Limited
    Inventors: Robert Walton, Eoin McKinney, Sara Marshall, Michael Murphy, Kenneth Welsh
  • Publication number: 20070141050
    Abstract: The invention provides a method of depleting anti-MHC antibodies in a sample comprising contacting said sample with one or more recombinant MHC molecules or functionally equivalent variants, derivatives or fragments thereof and removing at least the recombinant MHC molecules to which antibodies to said recombinant MHC molecules contained within the sample have bound. This method allows the depletion of one or more specific MHC particularly HLA allele antibodies from a sample.
    Type: Application
    Filed: April 25, 2006
    Publication date: June 21, 2007
    Inventors: Martin Barnardo, Andrea Harmer, Michael Bunce, Robert Vaughan, Kenneth Welsh